Society Testimony
Testimony from The Endocrine Society to the FDA on the Safety of Avandia
FY 2011 House Appropriations Testimony Regarding NIH Funding
Testimony of Carolyn Becker, MD, to the New York Medicaid Pharmacy and Therapeutics Committee on Levothyroxine Bioequivalence
Testimony of E. Chester Ridgway, MD, to the House Appropriations Committee on FY 2005 NIH Funding
Testimony of Daniel Spratt, MD, to the House Government Reform Committee on Obesity
Testimony of Marvin Gershengorn, MD, to the House Appropriations Committee on FY 2001 NIH Funding
- 34 KB)